top of page

About PhysioAge

PhysioAge was developed by Dr. Joseph Raffaele in his clinical practice.

He created PhysioAge to build tools that enable the delivery of world-class proactive medicine. Every service we offer has been designed, developed, and tested in his clinic, Raffaele Medical, before being offered to clinics around the world.

DR. RAFFAELE HAS BEEN FEATURED ON

Dr. Raffaele has appeared on National Public Radio and the local news broadcasts of NBC and ABC in New York, and has been quoted in The New York Times, Vogue, Elle, New York Post, and France’s Le Nouvel Observateur.

Research & Publications

A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response.

U.S. National Library of Medicine

A Natural Product Telomerase Activator as Part of a Health Maintenance Program

U.S. National Library of Medicine

A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study.

U.S. National Library of Medicine

Our Team

We’ve assembed a team of smart, passionate individuals who bring unique skills to the table.

JMR 2021 Headshot_edited.jpg

Joseph Raffaele received his BA in philosophy from Princeton University and his MD from Hahnemann University Medical School in 1989. Dr. Raffaele did his residency at The New York Hospital/Cornell University Medical Center and was formerly a clinical assistant professor of medicine at Dartmouth Medical School while in practice at the Hitchcock Clinic. Dr. Raffaele is a member of the American College of Physicians, is board certified in internal medicine, and is a diplomat of the American Board of Age management Medicine.

In 1995 Dr. Raffaele began researching and developing a scientifically-based treatment program and co-founded PhysioAge Medical Group. Since 1997 Dr. Raffaele has been focused on age management medicine and biomarkers of aging. As CEO of PhysioAge, Dr. Raffaele developed the combination of biomarkers currently in use and has worked with Dr. Kumm to develop PhysioAge formula.

Joseph M. Raffaele, MD

Founder and Chief Medical Officer

Jerry Fortunato received his BS in Finance from Rutgers University and his MBA from Rutgers Business School. He has been a Project Management Professional since 2003.

Jerry co-founded PhysioAge with Dr. Raffaele in 2008, where he is responsible for managing most business operations including marketing, sales, product management and technical support.

Jerry Fortunato, MBA, PMP

Co-Founder

Dan Powell has over fifteen years of startup, management, architecture, and development experience. He has spent most of his career solving large-scale data problems, focusing on high-volume data processing, web and mobile systems. Dan also has over 20 years of experience in the open source community including contributing to the development of the Linux kernel for DEC Alpha processors and the development of the Stampede Linux distribution. He studied mathematics and chemistry at North Carolina State University.

J. Daniel Powell

Chief Technology Officer

Jennifer Braun has been in clinical practice within the field of healthy aging for 10 years with a background in primary care and clinical research. She earned an MPH from UCLA and an MS in Physician Assistant Studies from Stony Brook University.

Jennifer joined PhysioAge in 2017 as a clinical advisor, supporting product management and development, as well as site support. She is also a clinical provider within Raffaele Medical where she develops customized treatment programs for her patients designed to achieve optimal health.

Jennifer Braun, MPH, PA

Director of Clinical Content

Dr. Fossel received a joint BA and MA in Psychology at Wesleyan University then, with perfect GRE scores, won an NSF fellowship to Stanford University, where he completed his Ph.D. in Neurobiology and his MD, and taught neuroanatomy, experimental design, and other courses. He began to focus on aging, progeria, and the experimental testing of aging theories. A clinical professor of medicine for almost 3 decades, he was the executive director for the American Aging Association, editor of several journals, and a frequent speaker and chair at global conferences. He has authored more than 100 articles, chapters, and books on aging, medicine, electronic health records, and medical ethics. His invited article, A Unified Model of Dementias and Age-related Neurodegeneration, and his parallel article, A Unified Model of Age-Related Cardiovascular Disease, outline a unified systems model for age-related CNS and CV diseases and offer a novel, feasible, and potentially more effective point of intervention for age related diseases. His textbooks and books for the general public have been translated into more than a dozen global editions and have been praised by both The London Times and The Wall Street Journal as among the best science books of the year. Dr. Fossel is the President of Telocyte, a biotech firm targeting CNS and other age-related diseases by using the telomerase gene therapy.

Michael B. Fossel, MD, PhD

Advisory Board

bottom of page